Moreover, a study involving the use of a mouse model reported that treatment with GLI-1 siRNA and GLI-2 siRNA markedly inhibited the progression and severity of interstitial pulmonary fibrosis [14]. The gene discussed is GLI2; the disease is pulmonary fibrosis.